The Development of a Permanent Implantable Spacer with the Function of Size Adjustability for Customized Treatment of Regurgitant Heart Valve Disease

Summary

Reports the development of a permanent implantable spacer whose size can be adjusted to each patient, intended for customized treatment of regurgitant heart valve disease.

Part of the research behind the Pivot‑TR platform for tricuspid regurgitation.